QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Quantify Research establishes subsidiary in Iceland
Quantify Research has established a subsidiary in Iceland called Íslensk heilsuhagfræði (Icelandic health economics), the country‘s first consultancy in the field. Gylfi Olafsson leads the new outfit located in Reykjavík. He will also continue working with Quantify Research at the Stockholm office.
Jonas Banefelt and Johan Mesterton co-author poster
Jonas Banefelt and Johan Mesterton co-authored the poster “Impact of PSA Doubling Time Calculation Method on Estimate of Association with Bone Metastases in a Cohort of Prostate Cancer Patients Treated with Androgen Deprivation Therapy”, which was presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Paper co-authored by Jonas Banefelt and Johan Mesterton presented at conference
The paper “Predictors of Clinical Metastases and Survival among Non-Metastatic Prostate Cancer Patients Treated with Androgen-Deprivation Therapy in Sweden”, co-authored by Jonas Banefelt and Johan Mesterton, was presented at the 29th International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Fredrik Borgström, Gylfi Olafsson and Oskar Ström in Osteoporosis International
Fredrik Borgström, Gylfi Olafsson and Oskar Ström have authored an article in Osteoporosis International that analyses the impact of different health dimensions on overall quality of life related to kyphoplasty and non-surgical management based on the FREE trial.
Link